Published in Am J Med on October 01, 1972
The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome. Ann Rheum Dis (1994) 2.03
T and B lymphocytes in peripheral blood and tissue lesions in Sjögren's syndrome. J Clin Invest (1974) 1.63
An immunohistological study of secondary Sjögren's syndrome. Ann Rheum Dis (1984) 1.36
IgA and IgM rheumatoid factors in serum, saliva and other secretions: relationship to immunoglobulin ratios in systemic sicca syndrome and rheumatoid arthritis. Clin Exp Immunol (1983) 1.14
Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren's syndrome and other sicca syndromes. Arthritis Res Ther (2011) 1.08
Cellular-versus-humoral autoimmune responses to salivary gland in Sjögren's syndrome. Clin Exp Immunol (1973) 0.87
Association of serum IgM kappa monoclonicity in patients with Sjögren's syndrome with an increased proportion of kappa positive plasma cells infiltrating the labial minor salivary glands. Ann Rheum Dis (1990) 0.81
T lymphocyte activation state in the minor salivary glands of patients with Sjögren's syndrome. Ann Rheum Dis (1987) 0.80
Chemical analysis of parotid saliva and lacrimal fluid in psoriatics. Arch Dermatol Res (1983) 0.75
Sjögren's syndrome: History, clinical and pathological features. Inflammopharmacology (1998) 0.75
Diagnosis of sarcoidosis by lip biopsy of minor salivary glands. Can Med Assoc J (1974) 0.75
Improvement in lacrimal and salivary secretions after alkali therapy in Sjøgren's syndrome with renal tubular acidosis. Ann Rheum Dis (1976) 0.75
The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1982) 67.54
Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis (2002) 20.48
Secretory immunoglobulins. Adv Immunol (1968) 7.00
Establishment and characterization of BALB/c lymphoma lines with B cell properties. J Immunol (1979) 6.70
Measurement of serum DNA-binding activity in systemic lupus erythematosus. N Engl J Med (1969) 6.16
Immune responses in vitro. 3. Development of primary gamma-M, gamma-G, and gamma-A plaque-forming cell responses in mouse spleen cell cultures stimulated with heterologous erythrocytes. J Exp Med (1971) 4.89
Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythmatosus. J Immunol (1969) 4.45
Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J Exp Med (1978) 4.28
Synergy among lymphoid cells mediating the graft-versus-host response. II. Synergy in graft-versus-host reactions produced by Balb-c lymphoid cells of differing anatomic origin. J Exp Med (1970) 4.14
Differentiation and characterization of autoantibodies and their antigens in Sjögren's syndrome. Arthritis Rheum (1976) 4.02
The pathogenesis of autoimmunity in New Zealand black mice. Curr Top Microbiol Immunol (1974) 3.98
The histopathology of Sjögren's syndrome in labial salivary gland biopsies. Oral Surg Oral Med Oral Pathol (1974) 3.82
Assignment of direct and facilitated hemolytic plaques in mice to specific immunoglobulin classes. J Immunol (1968) 3.81
Systemic tolerance and secretory immunity after oral immunization. J Exp Med (1980) 3.79
Synergy among lymphoid cells mediating the graft-versus-host response. 3. Evidence for interaction between two types of thymus-derived cells. J Exp Med (1972) 3.77
Suppression of immunoglobulin class synthesis in mice. I. Effects of treatment with antibody to -chain. J Exp Med (1972) 3.32
Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am J Pathol (1985) 3.31
Frequency of B lymphocytes responsive to anti-immunoglobulin. J Exp Med (1982) 3.30
Structure and function of immunoglobulin A. Prog Allergy (1972) 3.14
The human secretory immunoglobulin system: immunohistoligical localization of gamma A, secretory "piece," and lactoferrin in normal human tissues. J Exp Med (1969) 3.08
Extrasalivary lymphoid abnormalities in Sjögren's syndrome (reticulum cell sarcoma, "pseudolymphoma," macroglobulinemia). Am J Med (1967) 2.92
Xerostomia in Sjögren's syndrome. Evaluation by sequential salivary scintigraphy. JAMA (1971) 2.89
Activation of mouse lymphocytes by anti-immunoglobulin. I. Parameters of the proliferative response. J Exp Med (1978) 2.86
Relative inability to induce tolerance in adult NZB and NZB-NZW F1 mice. J Exp Med (1969) 2.78
Impaired Lymphocyte Transformation and Delayed Hypersensitivity in Sjögren's Syndrome. J Clin Invest (1967) 2.77
Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum (1988) 2.77
Evidence for an immunoglobulin-dependent antigen-specific helper T cell. Proc Natl Acad Sci U S A (1977) 2.72
Immunologic and viral factors in the pathogenesis of systemic lupus erythematosus. Arthritis Rheum (1971) 2.66
Disordered immunologic regulation and autoimmunity. Transplant Rev (1976) 2.62
Deficient interleukin 2 activity in MRL/Mp and C57BL/6J mice bearing the lpr gene. J Exp Med (1981) 2.46
Immune responses in vitro. IV. Suppression of primary M, G, and A plaque-forming cell responses in mouse spleen cell cultures by class-specific antibody to mouse immunoglobulins. J Exp Med (1972) 2.43
Fractionation of splenic antibody-forming cells on glass bead columns. J Immunol (1967) 2.41
Major urinary protein complex of normal mice: origin. Science (1965) 2.39
B cells expressing CD5 are increased in Sjögren's syndrome. Arthritis Rheum (1988) 2.37
Monoclonal antibodies against a specific surface determinant on malarial (Plasmodium knowlesi) merozoites block erythrocyte invasion. J Immunol (1981) 2.33
Androgenic hormones modulate autoantibody responses and improve survival in murine lupus. J Clin Invest (1977) 2.33
A Low Molecular Weight Immunoglobulin Antigenically Related to 19 S IgM. J Clin Invest (1967) 2.31
The pathogenesis of autoimmunity in New Zealand mice, I. Induction of antinucleic acid antibodies by polyinosinic-polycytidylic acid. Proc Natl Acad Sci U S A (1969) 2.31
An Lyt differentiated thymocyte subpopulation detected by flow microfluorometry. Nature (1979) 2.29
Immunoglobulin M: pentameric Fcmu fragments released by trypsin at higher temperatures. Proc Natl Acad Sci U S A (1970) 2.18
Oral tolerance. Transplantation (1980) 2.17
Synergy among lymphoid cells mediating the graft-versus-host response. I. Synergy in graft-versus-host reactions produced by cells from NZB-Bl mice. J Exp Med (1970) 2.15
DNA-binding assay for detection of anti-DNA antibodies in NZB-NZW F1 mice. J Immunol (1969) 2.13
Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitors. J Immunol (2000) 2.07
Suppression of the immune response by alpha-fetoprotein on the primary and secondary antibody response. J Exp Med (1975) 2.03
beta-Estradiol reduces natural killer cells in mice. J Immunol (1978) 2.02
The spectrum of benign to malignant lymphoproliferation in Sjögren's syndrome. Clin Exp Immunol (1972) 2.01
Minor salivary gland involvement in Sjögren's syndrome. Oral Surg Oral Med Oral Pathol (1974) 1.99
Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway. J Immunol (1984) 1.95
Serum concentrations and allotypes of immunoglobulins in two lines of mice genetically selected for "high" or "low" antibody synthesis. J Exp Med (1970) 1.93
Filter radioimmunoassay for antibodies to reovirus RNA in systemic lupus erythematosus. Arthritis Rheum (1974) 1.92
A hybridoma from an autoimmune NZB/NZW mouse producing monoclonal antibody to ribosomal-RNA. J Immunol (1980) 1.91
Interleukin 2 deficiency is a common feature of autoimmune mice. J Immunol (1981) 1.89
Establishment and characterization of a murine hybridoma secreting monoclonal anti-DNA autoantibody. J Immunol (1980) 1.88
In vitro studies of inflammatory bowel disease. Surface receptors of the mononuclear cell required to lyse allogeneic colonic epithelial cells. Gastroenterology (1976) 1.83
SITES OF FORMATION OF IMMUNE GLOBULINS AND OF A COMPONENT OF C'(3): I. A NEW TECHNIQUE FOR THE DEMONSTRATION OF THE SYNTHESIS OF INDIVIDUAL SERUM PROTEINS BY TISSUES IN VITRO. J Exp Med (1961) 1.83
Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosus. Clin Immunol Immunopathol (1984) 1.81
Immunological regulation of spontaneous antibodies to DNA and RNA. II. Sequential switch from IgM to IgG in NZB/NZW F1 mice. Immunology (1977) 1.80
The neuropathy of Sjögren's syndrome. Trigeminal nerve involvement. Ann Intern Med (1969) 1.79
Characterization of the nonphagocytic adherent cell from the peritoneal cavity of normal and BCG-treated mice. J Immunol (1977) 1.77
IA mutant functional antigen-presenting cell lines. J Immunol (1983) 1.76
The clearance and localization of nucleic acids by New Zealand and normal mice. Clin Exp Immunol (1972) 1.74
Secretory gamma-A in normal urine. J Clin Invest (1968) 1.74
Evidence for complement activation via the alternate pathway in skin diseases, I. Herpes gestationis, systemic lupus erythematosus, and bullous pemphigoid. J Clin Invest (1973) 1.73
Renal tubular acidosis, glomerulonephritis and immunologic factors in Sjögren's syndrome. Arthritis Rheum (1968) 1.72
B-lymphocyte heterogeneity: ontogenetic development and organ distribution of B-lymphocyte populations defined by their density of surface immunoglobulin. J Exp Med (1976) 1.72
The oral component of Sjögren's syndrome. Oral Surg Oral Med Oral Pathol (1975) 1.70
Cyclophosphamide in lupus nephritis: a controlled trial. Ann Intern Med (1971) 1.70
The life span of IgA plasma cells from the mouse intestine. J Exp Med (1973) 1.69
The pathogenesis of autoimmunity in New Zealand mice. 3. Factors influencing the formation of anti-nucleic acid antibodies. Immunology (1971) 1.68
Advances in the diagnosis and concept of Sjögren's syndrome (autoimmune exocrinopathy). Bull Rheum Dis (1980) 1.64
Genetic control of the antibody response to type 3 pneumococcal polysaccharide in mice. II. Relationship between IgM immunoglobulin levels and the ability to give an IgM antibody response. J Exp Med (1974) 1.64
T and B lymphocytes in peripheral blood and tissue lesions in Sjögren's syndrome. J Clin Invest (1974) 1.63
Studies on human intestinal immunoglobulin A. Gastroenterology (1971) 1.62
Interleukin-2 in rheumatoid arthritis: production of and response to interleukin-2 in rheumatoid synovial fluid, synovial tissue and peripheral blood. Clin Exp Immunol (1985) 1.61
Human immunoglobulin A: production of an Fc fragment by an enteric microbial proteolytic enzyme. J Immunol (1973) 1.60
Induction of immunologic tolerance in older New Zealand mice repopulated with young spleen, bone marrow, or thymus. J Exp Med (1970) 1.58
Use of serum amylase isoenzymes in evaluation of pancreatic function. Pediatrics (1974) 1.57
SLE-like autoantibodies and Sjögren's syndrome-like lymphoproliferation in TGF-beta knockout mice. J Immunol (1995) 1.57
Studies of thoracic duct lymphocytes of mice. I. Immunoglobulin synthesis in vitro. J Immunol (1968) 1.54
Evidence that the malignant lymphoma of Sjögren's syndrome is a monoclonal B-cell neoplasm. N Engl J Med (1978) 1.54
Response of NZB and NZB-NZW spleen cells to mitogenic agents. J Immunol (1970) 1.54
The effects of heterologous anti-thymocyte sera in mice. I. The use of a graft-vs.-host assay as a measure of homograft reactivity. J Immunol (1968) 1.53
Decreased autologous mixed lymphocyte reaction in Sjögren's syndrome. J Clin Invest (1980) 1.52
Studies of thoracic duct lymphocytes of mice. II. A quantitative comparison of the capacity of thoracic duct lymphocytes and other lymphoid cells to induce graft-versus-host reactions. J Immunol (1970) 1.49
Shared idiotypes and restricted immunoglobulin variable region heavy chain genes characterize murine autoantibodies of various specificities. J Clin Invest (1986) 1.48
Experimental murine amyloid. IV. Amyloidosis and immunoglobulins. J Immunol (1969) 1.48
I region-restricted antigen presentation by B cell-B lymphoma hybridomas. Nature (1982) 1.48
Structure and function of mucosal antibodies. Annu Rev Med (1970) 1.46